MRM Health NV Funding: $81M Raised, Series B (2025)
MRM Health NV has raised $81M in total funding. Latest round: Series B. Backed by Biocodex, Athos, BNP Paribas Private Fortis Equity.
MRM Health NV funding overview
MRM Health NV has raised $81M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in September 2025. The round record for MRM Health NV runs through 2025; nothing later has been disclosed. Investors on record include Biocodex, Athos, BNP Paribas Private Fortis Equity, Ackermans & van Haaren, DuPont Nutrition & Biosciures (IFF), OMX Europe Venture Fund. 6 distinct backers are named across the disclosed rounds.
MRM Health NV at a glance
Total raised
$81M
Latest round
Series B
Latest round date
September 2025
Notable investors
Biocodex, Athos, BNP Paribas Private Fortis Equity, Ackermans & van Haaren, DuPont Nutrition & Biosciures (IFF), OMX Europe Venture Fund
Frequently asked about MRM Health NV funding
How much has MRM Health NV raised?
MRM Health NV has raised $81M in total disclosed funding across the rounds on record.
Who has invested in MRM Health NV?
Biocodex, Athos, BNP Paribas Private Fortis Equity, Ackermans & van Haaren, DuPont Nutrition & Biosciures (IFF), OMX Europe Venture Fund are named among the investors backing MRM Health NV.
What was the latest MRM Health NV funding round?
The most recent disclosed round is a Series B, announced in September 2025.
Where is MRM Health NV based?
No headquarters location is disclosed for MRM Health NV.
When did MRM Health NV last raise?
The last disclosed MRM Health NV round closed in September 2025 at Series B.
MRM Health NV totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies below to benchmark round size and investor mix.
